enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Intuitive Surgical - Wikipedia

    en.wikipedia.org/wiki/Intuitive_Surgical

    In 2001, the FDA approved use of the system for prostate surgery. The FDA has subsequently approved the system for thoracoscopic surgery, cardiac procedures performed with adjunctive incisions, and gynecologic procedures. [6] Shortly before going public, Intuitive Surgical was sued for patent infringement by Computer Motion, Inc, its chief rival.

  3. Stress incontinence - Wikipedia

    en.wikipedia.org/wiki/Stress_incontinence

    Initially, the FDA approved implantable mesh devices due to their similarity to earlier prototypes, known as the 510(k) process. [ 16 ] [ 17 ] As patients allege long-term harm and suffering as a result of implanted mesh; the FDA released a safety communication in 2008, and led to the reclassification of surgical mesh to a class 3 or high risk ...

  4. Zanidatamab - Wikipedia

    en.wikipedia.org/wiki/Zanidatamab

    Zanidatamab, sold under the brand name Ziihera, is a humanized monoclonal antibody used for the treatment of HER2-positive biliary tract cancer. [1] [2] It is an IgG-like bispecific HER2-directed antibody directed against two non-overlapping domains of HER2.

  5. Scilex Holding Company Amends its License Agreement with ...

    lite.aol.com/tech/story/0022/20250116/9333476.htm

    Scilex’s commercial products include: (i) ZTlido® (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and Drug Administration (the “FDA”) for the relief of neuropathic pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain; (ii) ELYXYB®, a potential first ...

  6. VIVE: 12-Month SUI Feasibility Study Data Further Supports ...

    www.aol.com/news/vive-12-month-sui-feasibility...

    In addition to raising nearly $19M (net) via the sale of common shares, they recently announced compelling 12-month results from their n=36 SUI feasibility study and got the green light from FDA ...

  7. Nogapendekin alfa inbakicept - Wikipedia

    en.wikipedia.org/wiki/Nogapendekin_alfa_inbakicept

    Nogapendekin alfa inbakicept was approved for medical use in the United States in April 2024. [1] [6] [7] [8] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. [9]

  8. Merrimack Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Merrimack_Pharmaceuticals

    Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in the European Union the following year. [1] [2]

  9. The FDA Just Approved Opill, the First Over-the-Counter Birth ...

    www.aol.com/lifestyle/fda-just-approved-opill...

    On Thursday, the Food and Drug Administration (FDA) approved pharmaceutical company Perrigo’s Opill, the first over-the-counter birth control pill, which will let individuals obtain the ...